<p>加拿大不列顛哥倫比亞省温哥華，2026 年 1 月 22 日（GLOBE NEWSWIRE）——Cannabix Technologies Inc.（CSE: BLO）（OTCID: BLOZF）（法蘭克福: 8CT）（以下簡稱 “公司” 或 “Cannabix”）是一家大麻和酒精呼氣測試設備的開發商，欣然宣佈其大麻呼氣測試（“MBT”）將出現在 2026 年 AlcoPro Inc.產品目錄的封面上（見圖 1）。AlcoPro Inc.（“AlcoPro”）總部位於田納西州諾克斯維爾，是美國領先的專業藥物和酒精檢測儀器、工具和用品的供應商，自 1982 年以來為客户提供服務。2026 年 AlcoPro 產品目錄將分發給超過 85,000 家美國及國際企業，包括執法機構和矯正部門。</p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/d2807785-4c17-4e58-84d7-8fa78fc3e398/figure-1-cannabix-technologies-inc-marijuana-breath-test-featured-on-cover-of-2026-alcopro-final.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1600" height="2100" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/d2807785-4c17-4e58-84d7-8fa78fc3e398/figure-1-cannabix-technologies-inc-marijuana-breath-test-featured-on-cover-of-2026-alcopro-final.jpg"/></p>
<p>圖 1. Cannabix Technologies Inc.的大麻呼氣測試出現在 2026 年 AlcoPro Inc.產品目錄的封面上</p>
<p>Cannabix 與 AlcoPro 一直密切合作，主要在美國市場進行 MBT 的預發佈營銷活動。</p>
<p>大麻呼氣測試（MBT）系統結合了 Cannabix 的專有呼氣採集單元和呼氣卡匣技術，以捕獲和保存非侵入性的呼氣樣本，供黃金標準的 LC-MS 分析。Cannabix 與 Omega Laboratories Inc.的戰略合作伙伴關係——一家在法醫藥物檢測領域擁有超過 25 年經驗的全球領導者——為其提供了世界級的專業知識，得到了多個聯邦和國際認證的支持，並在藥物檢測方面擁有數十年的創新經驗。</p>
<p>AlcoPro 的業務發展總監 Brian Terry 表示：“我們對與 Cannabix Technologies 日益增長的關係以及 MBT 即將向我們的客户提供感到興奮。我們正在超越傳統的測試工具，轉向能夠提供當今工作場所所需準確性的先進技術。隨着安全挑戰的變化，保持領先地位，提供能夠主動降低風險的解決方案對於保護員工至關重要。”</p>
<p><strong>關於 AlcoPro, Inc.</strong> 自 1982 年以來，AlcoPro 一直是僱主、醫療專業人員、執法機構和藥物濫用專家信賴的藥物和酒精檢測解決方案的領導者。AlcoPro 以市場領先的呼氣測酒儀等可靠儀器而聞名，還提供創新的在線培訓，配備互動工具以增強知識保留。憑藉全面的產品目錄、便捷的在線訂購和專業支持，AlcoPro 使工作場所檢測變得簡單、準確和專業。瞭解更多信息，請訪問 www.AlcoPro.com。</p>
<p><strong>關於 Cannabix Technologies Inc.</strong> Cannabix Technologies Inc.是一家為執法機構、工作場所和實驗室開發大麻和酒精呼氣檢測技術的公司。Cannabix 正在開發 delta-9 THC 和酒精篩查設備。Delta-9 THC 是大麻中的主要精神活性成分。對 delta-9 THC 進行呼氣檢測將使僱主和執法機構能夠識別近期的大麻使用。Cannabix 是其_呼氣 Logix 系列呼氣酒精檢測設備_的開發者，適用於僱主和其他多種場合。</p>
<p>我們尋求安全港。</p>
<p><em>代表董事會</em></p>
<p>“Rav Mlait”</p>
<p>首席執行官</p>
<p>Cannabix Technologies Inc.</p>
<p>如需更多信息，請聯繫公司，郵箱為 <strong>info@cannabixtechnologies.com</strong></p>
<p><strong><em>關於前瞻性聲明的警示説明</em></strong></p>
<p>本新聞稿包含某些符合適用證券法下 “前瞻性聲明” 定義的內容。前瞻性聲明通常以 “預期”、“計劃”、“繼續”、“期望”、“項目”、“打算”、“相信”、“估計”、“可能”、“將”、“潛在”、“提議”、“定位” 等詞語或某些事件或條件 “可能” 或 “將” 發生的聲明為特徵。本新聞稿中的前瞻性聲明包括但不限於與以下內容相關的聲明：實現本新聞稿中描述的任何或所有目標和目的；商業或原型產品的最終開發；公司技術的成功試驗或試點；公司產品的商業化；與現有和新合作伙伴的額外協議的談判和潛在簽署；以及未來融資的完成。有許多風險和不確定性可能導致實際結果以及公司的計劃和目標與前瞻性信息中表達的內容存在重大差異。可能導致實際結果與前瞻性信息中表達的內容存在重大差異的重要因素包括（但不限於）：不利的市場條件；關於保護專有技術的風險；公司完成未來融資的能力；公司開發和營銷未來產品的能力；關於政府監管、管理和維持增長的風險、不利宣傳的影響、訴訟、競爭；合作伙伴可能無法完成所有或任何戰略合作協議中設想的里程碑；CSE 可能不批准證券的發行；公司開發的呼氣分析儀技術是否會為公司帶來任何好處沒有保證；沒有保證任何提議的新產品會被建造、在測試或臨牀試驗中成功；沒有保證公司會與任何合作伙伴建立合作關係以推進其任何企業計劃或技術；沒有保證公司許可或擁有的任何 “專利申請” 或 “臨時專利” 技術會獲得監管機構的專利狀態；公司目前並未銷售呼氣分析儀，也沒有保證公司將來會銷售；以及其他超出公司控制的因素。實際結果和未來事件可能與預期的信息存在重大差異。這些及所有後續的書面和口頭前瞻性信息均基於管理層在作出聲明時的估計和意見，並完全受到本通知的明確限定。除法律要求外，公司不打算更新這些前瞻性聲明。</p>
<p>CSE 未對本發佈的充分性或準確性進行審查，也不承擔任何責任。</p>
<p>與本公告相關的照片可在 https://www.globenewswire.com/NewsRoom/AttachmentNg/d2807785-4c17-4e58-84d7-8fa78fc3e398 獲取。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1ESTNNU00zTXpjME5UazNJekl3T0RjeE1qTT0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1ESTNNU00zTXpjME5UazNJekl3T0RjeE1qTT0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGQzNDI5NDgtNmM2MS00NDg2LWExMzUtZTc3ZTZlNTlkZTg1LTEwOTg2OTQtMjAyNi0wMS0yMi1lbg==/tiny/Cannabix-Technologies-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGQzNDI5NDgtNmM2MS00NDg2LWExMzUtZTc3ZTZlNTlkZTg1LTEwOTg2OTQtMjAyNi0wMS0yMi1lbg==/tiny/Cannabix-Technologies-Inc-.png"/></p>

CBIH

CBSTF

<p>Cannabix Technologies Inc. 宣佈其大麻呼吸測試（MBT）將出現在 AlcoPro 2026 產品目錄的封面上。AlcoPro 是一家領先的藥物和酒精檢測儀器供應商，將向超過 85,000 家企業分發該目錄。MBT 結合了 Cannabix 的呼吸採集單元和呼吸 cartridge 技術，以實現準確的呼吸樣本分析。與 Omega Laboratories 的合作增強了 Cannabix 在藥物檢測方面的專業知識。AlcoPro 的業務發展總監對這一合作以及 MBT 提高工作場所安全的潛力表示興奮</p>

<p>VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and alcohol breath-testing devices, is pleased to announce that its Marijuana Breath Test (“MBT”) will be featured on the cover of the 2026 AlcoPro Inc. product catalogue (see Figure 1). AlcoPro Inc. (“AlcoPro”), based in Knoxville, TN, is a leading U.S. supplier of professional drug and alcohol testing instruments, kits, and supplies, serving customers since 1982. The 2026 AlcoPro product catalogue will be distributed to more than 85,000 businesses across the United States and internationally including law enforcement and the corrections segment.</p>
<div class="lb-trans"><p>加拿大不列顛哥倫比亞省温哥華，2026 年 1 月 22 日（GLOBE NEWSWIRE）——Cannabix Technologies Inc.（CSE: BLO）（OTCID: BLOZF）（法蘭克福: 8CT）（以下簡稱 “公司” 或 “Cannabix”）是一家大麻和酒精呼氣測試設備的開發商，欣然宣佈其大麻呼氣測試（“MBT”）將出現在 2026 年 AlcoPro Inc.產品目錄的封面上（見圖 1）。AlcoPro Inc.（“AlcoPro”）總部位於田納西州諾克斯維爾，是美國領先的專業藥物和酒精檢測儀器、工具和用品的供應商，自 1982 年以來為客户提供服務。2026 年 AlcoPro 產品目錄將分發給超過 85,000 家美國及國際企業，包括執法機構和矯正部門。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/Resource/Download/d2807785-4c17-4e58-84d7-8fa78fc3e398/figure-1-cannabix-technologies-inc-marijuana-breath-test-featured-on-cover-of-2026-alcopro-final.jpg" alt="" original-src="https://ml.globenewswire.com/Resource/Download/d2807785-4c17-4e58-84d7-8fa78fc3e398/figure-1-cannabix-technologies-inc-marijuana-breath-test-featured-on-cover-of-2026-alcopro-final.jpg"/></p>
<p>Figure 1. Cannabix Technologies Inc. Marijuana Breath Test featured on cover of 2026 AlcoPro, Inc. product catalog</p>
<div class="lb-trans"><p>圖 1. Cannabix Technologies Inc.的大麻呼氣測試出現在 2026 年 AlcoPro Inc.產品目錄的封面上</p>
</div><p>Cannabix and AlcoPro have been working closely together on pre-launch marketing activities for the MBT primarily in the U.S. market.</p>
<div class="lb-trans"><p>Cannabix 與 AlcoPro 一直密切合作，主要在美國市場進行 MBT 的預發佈營銷活動。</p>
</div><p>The Marijuana Breath Test (MBT) system brings together Cannabix’s proprietary Breath Collection Unit and Breath Cartridge technologies to capture and preserve non-invasive breath samples for gold-standard LC-MS analysis. Cannabix’s strategic partnership with Omega Laboratories Inc.—a global leader in forensic drug testing for more than 25 years—adds world-class expertise, backed by multiple federal and international certifications and decades of innovation in drug detection.</p>
<div class="lb-trans"><p>大麻呼氣測試（MBT）系統結合了 Cannabix 的專有呼氣採集單元和呼氣卡匣技術，以捕獲和保存非侵入性的呼氣樣本，供黃金標準的 LC-MS 分析。Cannabix 與 Omega Laboratories Inc.的戰略合作伙伴關係——一家在法醫藥物檢測領域擁有超過 25 年經驗的全球領導者——為其提供了世界級的專業知識，得到了多個聯邦和國際認證的支持，並在藥物檢測方面擁有數十年的創新經驗。</p>
</div><p>Brian Terry, Director of Business Development of AlcoPro stated, “We are exciting about our growing relationship with Cannabix Technologies, and the upcoming availability of the MBT to our clients. We’re moving beyond traditional testing tools and leaning into advanced technologies that deliver the accuracy today’s workplaces demand. As safety challenges shift, staying ahead with solutions that proactively reduce risk is essential to protecting employees.”</p>
<div class="lb-trans"><p>AlcoPro 的業務發展總監 Brian Terry 表示：“我們對與 Cannabix Technologies 日益增長的關係以及 MBT 即將向我們的客户提供感到興奮。我們正在超越傳統的測試工具，轉向能夠提供當今工作場所所需準確性的先進技術。隨着安全挑戰的變化，保持領先地位，提供能夠主動降低風險的解決方案對於保護員工至關重要。”</p>
</div><p><strong>About AlcoPro, Inc.</strong> Since 1982, AlcoPro has been a trusted leader in drug and alcohol testing solutions for employers, healthcare professionals, law enforcement, and substance abuse specialists. Known for reliable instruments like market-leading breathalyzers, AlcoPro also offers innovative online training with interactive tools to enhance knowledge retention. With a comprehensive product catalog, easy online ordering, and expert support, AlcoPro makes workplace testing simple, accurate, and professional. Learn more at www.AlcoPro.com.</p>
<div class="lb-trans"><p><strong>關於 AlcoPro, Inc.</strong> 自 1982 年以來，AlcoPro 一直是僱主、醫療專業人員、執法機構和藥物濫用專家信賴的藥物和酒精檢測解決方案的領導者。AlcoPro 以市場領先的呼氣測酒儀等可靠儀器而聞名，還提供創新的在線培訓，配備互動工具以增強知識保留。憑藉全面的產品目錄、便捷的在線訂購和專業支持，AlcoPro 使工作場所檢測變得簡單、準確和專業。瞭解更多信息，請訪問 www.AlcoPro.com。</p>
</div><p><strong>About Cannabix Technologies Inc.</strong> Cannabix Technologies Inc. is a developer of marijuana and alcohol breathalyzer technologies for law enforcement, workplaces and laboratories. Cannabix is developing delta-9 THC and alcohol screening devices. Delta-9 THC is the primary psychoactive ingredient in cannabis. Breath testing for delta-9 THC would allow employers and law enforcement to identify recent marijuana use. Cannabix is the developer of its <em>Breath Logix Series of breath alcohol detection devices</em> for employers and a range of other settings.</p>
<div class="lb-trans"><p><strong>關於 Cannabix Technologies Inc.</strong> Cannabix Technologies Inc.是一家為執法機構、工作場所和實驗室開發大麻和酒精呼氣檢測技術的公司。Cannabix 正在開發 delta-9 THC 和酒精篩查設備。Delta-9 THC 是大麻中的主要精神活性成分。對 delta-9 THC 進行呼氣檢測將使僱主和執法機構能夠識別近期的大麻使用。Cannabix 是其_呼氣 Logix 系列呼氣酒精檢測設備_的開發者，適用於僱主和其他多種場合。</p>
</div><p>We seek Safe Harbor.</p>
<div class="lb-trans"><p>我們尋求安全港。</p>
</div><p><em>On behalf of the Board of Directors</em></p>
<div class="lb-trans"><p><em>代表董事會</em></p>
</div><p>“Rav Mlait”</p>
<div class="lb-trans"><p>“Rav Mlait”</p>
</div><p>CEO</p>
<div class="lb-trans"><p>首席執行官</p>
</div><p>Cannabix Technologies Inc.</p>
<div class="lb-trans"><p>Cannabix Technologies Inc.</p>
</div><p>For further information, contact the Company at <strong>info@cannabixtechnologies.com</strong></p>
<div class="lb-trans"><p>如需更多信息，請聯繫公司，郵箱為 <strong>info@cannabixtechnologies.com</strong></p>
</div><p><strong><em>Cautionary Statement Regarding Forward-Looking Statements</em></strong></p>
<div class="lb-trans"><p><strong><em>關於前瞻性聲明的警示説明</em></strong></p>
</div><p><em>This news release contains certain &#34;forward-looking statements&#34; within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as &#34;anticipates,&#34; &#34;plan,&#34; &#34;continue,&#34; &#34;expect,&#34; &#34;project,&#34; &#34;intend,&#34; &#34;believe,&#34; &#34;anticipate,&#34; &#34;estimate,&#34; &#34;may,&#34; &#34;will,&#34; &#34;potential,&#34; &#34;proposed,&#34; &#34;positioned&#34; and other similar words, or statements that certain events or conditions &#34;may&#34; or &#34;will&#34; occur. Forward-looking statements in this news release include, but are not limited to, statements relating to: the achievement of any or all of the goals and aims as described in this news release; final development of a commercial or prototype product(s); the successful trial or pilot of company technologies; the commercialization of the Company's products; the negotiation and potential entry into additional agreements with existing and new partners; and the completion of future financings. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information. Important factors that could cause actual results to differ materially from those expressed in the forward-looking information include (but are note limited to): adverse market conditions; risks regarding protection of proprietary technology; the ability of the Company to complete future financings; the ability of the Company to develop and market its future product; risks regarding government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition; that partners may not complete all or any of the milestones as contemplated strategic partnership agreements; that the CSE may not approve the issuance of the securities; that the Company’s development of breathalyzer technology will provide any benefit to the Company; there is no assurance that any proposed new products will be built, will be successful in beta testing or clinical trials; there is no assurance that the Company will enter into any partnerships to advance any of its corporate initiatives or technologies; there is no assurance that any “patent pending” or “provisional patents” technologies licensed by the Company or owned by the Company will receive patent status by regulatory authorities; the Company is not currently selling breathalyzers and there is no assurance that the Company ever will; and other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.</em></p>
<div class="lb-trans"><p>本新聞稿包含某些符合適用證券法下 “前瞻性聲明” 定義的內容。前瞻性聲明通常以 “預期”、“計劃”、“繼續”、“期望”、“項目”、“打算”、“相信”、“估計”、“可能”、“將”、“潛在”、“提議”、“定位” 等詞語或某些事件或條件 “可能” 或 “將” 發生的聲明為特徵。本新聞稿中的前瞻性聲明包括但不限於與以下內容相關的聲明：實現本新聞稿中描述的任何或所有目標和目的；商業或原型產品的最終開發；公司技術的成功試驗或試點；公司產品的商業化；與現有和新合作伙伴的額外協議的談判和潛在簽署；以及未來融資的完成。有許多風險和不確定性可能導致實際結果以及公司的計劃和目標與前瞻性信息中表達的內容存在重大差異。可能導致實際結果與前瞻性信息中表達的內容存在重大差異的重要因素包括（但不限於）：不利的市場條件；關於保護專有技術的風險；公司完成未來融資的能力；公司開發和營銷未來產品的能力；關於政府監管、管理和維持增長的風險、不利宣傳的影響、訴訟、競爭；合作伙伴可能無法完成所有或任何戰略合作協議中設想的里程碑；CSE 可能不批准證券的發行；公司開發的呼氣分析儀技術是否會為公司帶來任何好處沒有保證；沒有保證任何提議的新產品會被建造、在測試或臨牀試驗中成功；沒有保證公司會與任何合作伙伴建立合作關係以推進其任何企業計劃或技術；沒有保證公司許可或擁有的任何 “專利申請” 或 “臨時專利” 技術會獲得監管機構的專利狀態；公司目前並未銷售呼氣分析儀，也沒有保證公司將來會銷售；以及其他超出公司控制的因素。實際結果和未來事件可能與預期的信息存在重大差異。這些及所有後續的書面和口頭前瞻性信息均基於管理層在作出聲明時的估計和意見，並完全受到本通知的明確限定。除法律要求外，公司不打算更新這些前瞻性聲明。</p>
</div><p><em>The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.</em></p>
<div class="lb-trans"><p>CSE 未對本發佈的充分性或準確性進行審查，也不承擔任何責任。</p>
</div><p>A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d2807785-4c17-4e58-84d7-8fa78fc3e398</p>
<div class="lb-trans"><p>與本公告相關的照片可在 https://www.globenewswire.com/NewsRoom/AttachmentNg/d2807785-4c17-4e58-84d7-8fa78fc3e398 獲取。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZek1ESTNNU00zTXpjME5UazNJekl3T0RjeE1qTT0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYzMDI3MSM3Mzc0NTk3IzIwODcxMjM="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGQzNDI5NDgtNmM2MS00NDg2LWExMzUtZTc3ZTZlNTlkZTg1LTEwOTg2OTQtMjAyNi0wMS0yMi1lbg==/tiny/Cannabix-Technologies-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/MGQzNDI5NDgtNmM2MS00NDg2LWExMzUtZTc3ZTZlNTlkZTg1LTEwOTg2OTQtMjAyNi0wMS0yMi1lbg==/tiny/Cannabix-Technologies-Inc-.png"/></p>

Cannabix 大麻呼吸測試儀被選為 AlcoPro 2026 年產品目錄的封面產品 | BLOZF 股票新聞